Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Diabetes Technology & Therapeutics|July 15, 2026
Use of Low-Glucose Alerts and Their Impact on Continuous Glucose Monitoring Outcomes in Real-World Use of the MiniMed 780G SystemJavier Castañeda, Margaret Liu, Joanna Juachon, et al.
Diabetes Care|July 22, 2016
When Intensive Insulin Therapy (MDI) Fails in Patients With Type 2 Diabetes: Switching to GLP-1 Receptor Agonist Versus Insulin PumpOhad Cohen, Sebastiano Filetti, Javier Castañeda, et al.
Diabetes, Obesity & Metabolism|May 29, 2023
The significance of coefficient of variation as a measure of hypoglycaemia risk and glycaemic control in real world users of the automated insulin delivery MiniMed 780G systemJavier Castañeda, Arcelia Arrieta, Tim van den Heuvel, et al.
Acta Diabetologica|June 5, 2025
Use of the temporary glycemic target feature in the medtronic MiniMed™ 780G advanced hybrid closed loop system: a real-world evidence studyJeremy Basset-Sagarminaga, Tim van den Heuvel, Javier Castañeda, et al.
Diabetes Care|December 19, 2023
Time in Tight Glucose Range in Type 1 Diabetes: Predictive Factors and Achievable Targets in Real-World Users of the MiniMed 780G SystemJavier Castañeda, Arcelia Arrieta, Tim van den Heuvel, et al.
Diabetes Technology & Therapeutics|February 20, 2024
Celebrating the Data from 100,000 Real-World Users of the MiniMed™ 780G System in Europe, Middle East, and Africa Collected Over 3 Years: From Data to Clinical EvidencePratik Choudhary, Arcelia Arrieta, Tim van den Heuvel, et al.
Diabetes Technology & Therapeutics|February 20, 2024
Future of Time-in-Range Goals in the Era of Advanced Hybrid Closed-Loop Automated Insulin Delivery SystemsHalis K Akturk, Tadej Battelino, Javier Castañeda, et al.
Diabetes, Obesity & Metabolism|November 28, 2025
A narrative review of meal management with the MiniMed™ 780G system: Evolution of dietary management in type 1 diabetesShannon Edd, Maya Laron-Hirsch, Javier Castañeda, et al.
Diabetes, Obesity & Metabolism|July 6, 2022
Predictors of time in target glucose range in real-world users of the MiniMed 780G systemJavier Castañeda, Chantal Mathieu, Henk-Jan Aanstoot, et al.
Diabetes Technology & Therapeutics|September 15, 2021
Real-World Performance of the MiniMed™ 780G System: First Report of Outcomes from 4120 UsersJulien Da Silva, Giuseppe Lepore, Tadej Battelino, et al.
Pageof 4